DR. HUGH BRENT SOLVASON, MD PHD
Psychiatric in Palo Alto, CA
License number
California G081228
Category
Psychiatric
Type
Psychiatry
Address
Address
401 Department Of Psychiatry RM 2138, Palo Alto, CA 94304
Phone
(650) 723-2749
(650) 723-8331 (Fax)
(650) 723-8331 (Fax)
Professional information
Dr. Hugh B Solvason, Palo Alto CA - MD (Doctor of Medicine)
Specialties:
Psychiatry, Neuropsychiatry (Psychiatry)
Address:
Palo Alto Office
401 Quarry Rd, Palo Alto 94304
(650) 723-6643 (Phone)
401 Quarry Rd, Palo Alto 94304
(650) 723-6643 (Phone)
Certifications:
Psychiatry, 2012
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Palo Alto Office
401 Quarry Rd, Palo Alto 94304
Montefiore Medical Center - Wakefield
600 East 233Rd St, Bronx 10466
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
401 Quarry Rd, Palo Alto 94304
Montefiore Medical Center - Wakefield
600 East 233Rd St, Bronx 10466
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
University Of Alabama School Of Medicine
Graduated: 1993
Stanford University Hospital
Graduated: 1994
Graduated: 1997
Graduated: 1998
University Of Alabama School Of Medicine
Graduated: 1993
Stanford University Hospital
Graduated: 1994
Graduated: 1997
Graduated: 1998
Hugh Brent Solvason, Stanford CA
Specialties:
Psychiatry
Work:
Psychiatry Department
401 Quarry Rd, Stanford, CA 94305
401 Quarry Rd, Stanford, CA 94305
Education:
University of Alabama at Birmingham (1993)
Treatment Of Refractory Neuropsychiatric Disorders Using Targeted Radiation
US Patent:
2013028, Oct 24, 2013
Filed:
Apr 18, 2013
Appl. No.:
13/865903
Inventors:
Hugh Brent Solvason - Stanford CA, US
John R. Adler - Stanford CA, US
John R. Adler - Stanford CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
A61N 5/10
US Classification:
600 1
Abstract:
Provided herein are methods for treating neuropsychiatric disorders by delivering radiation to an area in the subgenual anterior cingulate cortex, particularly to the cingulate area 25. Those methods are also beneficial to treat refractory neuropsychiatric disorders.